Chase Knickerbocker
Stock Analyst at Craig-Hallum
(4.83)
# 88
Out of 5,182 analysts
46
Total ratings
70.59%
Success rate
41.75%
Average return
Main Sectors:
Stocks Rated by Chase Knickerbocker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDXG MiMedx Group | Maintains: Buy | $10 → $7 | $3.31 | +111.48% | 3 | Apr 17, 2026 | |
| ACOG Alpha Cognition | Initiates: Buy | $14 | $6.99 | +100.29% | 1 | Apr 17, 2026 | |
| NRXS NeurAxis | Maintains: Buy | $8 → $13 | $7.51 | +73.10% | 3 | Mar 20, 2026 | |
| ETON Eton Pharmaceuticals | Maintains: Buy | $30 → $35 | $23.61 | +48.24% | 8 | Mar 20, 2026 | |
| HROW Harrow | Maintains: Buy | $54 → $64 | $39.14 | +63.52% | 4 | Sep 23, 2025 | |
| FENC Fennec Pharmaceuticals | Maintains: Buy | $13 → $14 | $6.70 | +109.11% | 6 | Aug 15, 2025 | |
| PYPD PolyPid | Maintains: Buy | $15 → $13 | $4.71 | +176.01% | 2 | Aug 14, 2025 | |
| XERS Xeris Biopharma Holdings | Maintains: Buy | $6.5 → $11 | $6.04 | +82.12% | 2 | Aug 8, 2025 | |
| DMAC DiaMedica Therapeutics | Maintains: Buy | $8 → $11 | $6.47 | +70.02% | 1 | Jul 18, 2025 | |
| BFLY Butterfly Network | Initiates: Buy | $3 | $5.53 | -45.75% | 1 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $17 | $11.73 | +44.93% | 3 | Jun 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $39 | $17.08 | +128.34% | 1 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $8 | $4.18 | +91.39% | 4 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $21 | $11.19 | +87.67% | 2 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $6 | $4.11 | +45.99% | 2 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $8.74 | +14.42% | 1 | Jul 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1 → $1.2 | $0.52 | +132.56% | 2 | Jul 11, 2023 |
MiMedx Group
Apr 17, 2026
Maintains: Buy
Price Target: $10 → $7
Current: $3.31
Upside: +111.48%
Alpha Cognition
Apr 17, 2026
Initiates: Buy
Price Target: $14
Current: $6.99
Upside: +100.29%
NeurAxis
Mar 20, 2026
Maintains: Buy
Price Target: $8 → $13
Current: $7.51
Upside: +73.10%
Eton Pharmaceuticals
Mar 20, 2026
Maintains: Buy
Price Target: $30 → $35
Current: $23.61
Upside: +48.24%
Harrow
Sep 23, 2025
Maintains: Buy
Price Target: $54 → $64
Current: $39.14
Upside: +63.52%
Fennec Pharmaceuticals
Aug 15, 2025
Maintains: Buy
Price Target: $13 → $14
Current: $6.70
Upside: +109.11%
PolyPid
Aug 14, 2025
Maintains: Buy
Price Target: $15 → $13
Current: $4.71
Upside: +176.01%
Xeris Biopharma Holdings
Aug 8, 2025
Maintains: Buy
Price Target: $6.5 → $11
Current: $6.04
Upside: +82.12%
DiaMedica Therapeutics
Jul 18, 2025
Maintains: Buy
Price Target: $8 → $11
Current: $6.47
Upside: +70.02%
Butterfly Network
Jul 1, 2025
Initiates: Buy
Price Target: $3
Current: $5.53
Upside: -45.75%
Jun 9, 2025
Maintains: Buy
Price Target: $12 → $17
Current: $11.73
Upside: +44.93%
Feb 28, 2025
Initiates: Buy
Price Target: $39
Current: $17.08
Upside: +128.34%
Jan 22, 2025
Maintains: Buy
Price Target: $10 → $8
Current: $4.18
Upside: +91.39%
Jan 17, 2025
Maintains: Buy
Price Target: $18 → $21
Current: $11.19
Upside: +87.67%
Jan 17, 2025
Maintains: Buy
Price Target: $5 → $6
Current: $4.11
Upside: +45.99%
Jul 11, 2024
Initiates: Buy
Price Target: $10
Current: $8.74
Upside: +14.42%
Jul 11, 2023
Maintains: Buy
Price Target: $1 → $1.2
Current: $0.52
Upside: +132.56%